SEI — Qualitative And Quantitative Hepatitis B Virus Antibody Assays Class II

FDA Device Classification

FDA product code SEI covers "Qualitative And Quantitative Hepatitis B Virus Antibody Assays", a Class II medical device regulated under 21 CFR 866.3173. Submissions are reviewed by the Microbiology panel. At least 4 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
SEI
Device Class
Class II
Regulation Number
866.3173
Submission Type
510(k)
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

In vitro diagnostic devices intended for use in the detection of antibodies to HBV. These devices are intended to aid in the diagnosis of HBV infection in persons with signs and symptoms of hepatitis and in persons at risk for HBV infection. Anti-HBs assay results may be used as an aid in the determination of susceptibility to HBV infection in individuals prior to or following HBV vaccination or when vaccination status is unknown.

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K260049Roche DiagnosticsElecsys Anti-HBc IgMApr 7, 2026
K260046Roche DiagnosticsElecsys Anti-HBc IIApr 7, 2026
K254059Beckman CoulterAccess anti-HBc IgMMar 13, 2026
K253687Beckman CoulterAccess anti-HBc TotalFeb 19, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.